Ovarian Cancer News and Research

Latest Ovarian Cancer News and Research

Gene mapping project promises new targeted cancer therapies

Government researchers in the United States have this week launched a pilot project to find all the little genetic changes that cause cancer in the hope it will lead to a whole new world of targeted cancer therapy.

14 Dec 2005

Tea lowers ovarian cancer risk

Women who drank at least two cups of tea a day had a lower risk of ovarian cancer than those who did not drink tea, according to a study in the December 12/26 issue of Archives of Internal Medicine.

13 Dec 2005

A cuppa a day keeps cancer away

According to a Swedish study, women who drink two or more cups of tea per day may dramatically cut their risk of ovarian cancer.

12 Dec 2005

Phenoxodiol - docetaxel combination for women with recurrent ovarian cancer

A clinical study of ovarian cancer initiated by investigators at Yale School of Medicine will combine the anti-cancer drug phenoxodiol with docetaxel for women with recurrent ovarian cancer.

5 Dec 2005

Genetic profile of ovarian cancer

A newly identified gene expression profile could help predict how patients with advanced ovarian cancer will respond to chemotherapy treatment.

7 Nov 2005

Lack of gene expression associated with ovarian cancer

The expression of two specific genes is almost completely downregulated in ovarian cancer tumours. An extensive analysis of gene expression in ovarian cancer tumour cells has revealed this important finding, which should be an aid to early diagnosis.

24 Oct 2005

Access to genetic counseling and testing are an important part of cancer control

Ten years after the identification of the first breast cancer susceptibility genes so few high-risk minority women have received genetic counseling or testing that the standard methods of calculating risk have not been validated in these groups and the results of genetic testing can still produce surprises.

18 Oct 2005

Data supports use of personal and family history of breast cancer, ovarian cancer, or both in making clinical decisions

African American women at high-risk of breast cancer have genetic mutations that would make genetic testing feasible, according to a study in the October 19 issue of JAMA: The Journal of the American Medical Association.

18 Oct 2005

Removing metastatic disease from the diaphragm significantly increases survival rates in ovarian cancer patients

In a retrospective study looking back at a decade of surgeries, Mayo Clinic Cancer Center researchers have determined that surgery to remove metastatic disease from the diaphragm, in conjunction with other procedures to remove the primary diseased tissue in ovarian cancer patients, significantly increases survival rates.

12 Oct 2005

Common cancer susceptibility gene appears to be frequently acquired in metastatic lesions from colorectal cancer

A relatively common cancer susceptibility gene appears to be frequently acquired in metastatic lesions from colorectal cancer, and give cancer cells a growth advantage, according to a study in the October 5 issue of JAMA: The Journal of the American Medical Association.

4 Oct 2005

Discovery establishes a role for the gene Rsf-1 in ovarian cancer

Johns Hopkins Kimmel Cancer Center researchers have linked alterations in a gene, called Rsf-1, to the most deadly ovarian cancers. The scientists say the discovery is the first to establish a role for the gene in ovarian cancer and may lead to a test that can predict, early on, which patients will develop aggressive disease.

3 Oct 2005

Researchers at Johns Hopkins have identified three new genetic mutations in brain tumors

...a discovery that could pave the way for more effective cancer treatments.

27 Sep 2005

Mutations in receptor tyrosine kinases provide potential for highly-targeted cancer therapies

Scientists from J. Craig Venter Institute, Ludwig Institute for Cancer Research, and The Johns Hopkins University School of Medicine identified three novel mutations in two receptor tyrosine kinases in glioblastoma tumors using high throughput sequencing.

26 Sep 2005

State-of-the-art treatment program increases survival from the aggressive uterine papillary serous carcinoma

"Our study defines a standard of care for this aggressive and growing form of uterine cancer," said Schwartz, who is also assistant chief of obstetrics and gynecology at Yale-New Haven Hospital. The procedure more accurately determines the complete stage and appropriate treatment and reduces the recurrence of the cancer.

26 Sep 2005

Simple, fast and effective method of detecting a large number of patients at high risk for hereditary breast/ovarian cancer

One in five women diagnosed with breast or ovarian cancer who seek mammography have a family history of cancer that suggests they may harbor known cancer-causing gene mutations.

26 Sep 2005

Questionnaire helps identify women who have inherited genetic mutations that increase their risk for breast or ovarian cancer

A simplified way for patients to report and update their family medical histories could help identify women who have inherited genetic mutations that increase their risk for breast or ovarian cancer.

26 Sep 2005

Increased ovarian cancer risk not linked to cancer family history

Women with a strong family history of breast cancer but who don't have breast cancer genetic mutations can now be reassured that they are not at increased risk for ovarian cancer, according to a new study by researchers at Memorial Sloan-Kettering Cancer Center (MSKCC).

21 Sep 2005

Ovarian Cancer News and Research

Latest Ovarian Cancer News and Research

Gene mapping project promises new targeted cancer therapies

Tea lowers ovarian cancer risk

A cuppa a day keeps cancer away

Phenoxodiol - docetaxel combination for women with recurrent ovarian cancer

Genetic profile of ovarian cancer

Lack of gene expression associated with ovarian cancer

Access to genetic counseling and testing are an important part of cancer control

Data supports use of personal and family history of breast cancer, ovarian cancer, or both in making clinical decisions

Removing metastatic disease from the diaphragm significantly increases survival rates in ovarian cancer patients

Common cancer susceptibility gene appears to be frequently acquired in metastatic lesions from colorectal cancer

Discovery establishes a role for the gene Rsf-1 in ovarian cancer

Researchers at Johns Hopkins have identified three new genetic mutations in brain tumors

Mutations in receptor tyrosine kinases provide potential for highly-targeted cancer therapies

State-of-the-art treatment program increases survival from the aggressive uterine papillary serous carcinoma

Simple, fast and effective method of detecting a large number of patients at high risk for hereditary breast/ovarian cancer

Questionnaire helps identify women who have inherited genetic mutations that increase their risk for breast or ovarian cancer

Increased ovarian cancer risk not linked to cancer family history

Translation elongation factor eEF1A2 is is a potential oncogene that is overexpressed in two-thirds of breast tumors

Testing for specific breast cancer genes unadvisable if no family history of disease exists

New recommendations for screening for BRCA1 and BRCA2 gene mutations

Precision in every drop: Inside Hamilton’s syringe technology

Exploring the Future of Neuroscience Drug Discovery

Genomic conservation in Thailand's mangroves

Ovarian Cancer News and Research

Latest Ovarian Cancer News and Research

Precision in every drop: Inside Hamilton’s syringe technology

Exploring the Future of Neuroscience Drug Discovery

Genomic conservation in Thailand's mangroves

Newsletters you may be interested in